Journal of Diabetes Research

Diabetic Neuropathy: New Insights to Early Diagnosis and Treatments


Publishing date
01 Dec 2018
Status
Published
Submission deadline
27 Jul 2018

Lead Editor

1University of Iowa, Iowa City, USA

2University of Manchester, Manchester, UK

3University of California, San Diego, USA

4Eastern Virginia Medical School, Norfolk, USA

5Hirosaki University Graduate School of Medicine, Hirosaki, Japan


Diabetic Neuropathy: New Insights to Early Diagnosis and Treatments

Description

Diabetic neuropathy is a complex disorder with multiple etiologies that affects about 50% of the diabetes population. At this time there is no known treatment. Good glycemic control slows progression of diabetic neuropathy in subjects with type 1 diabetes but seems to provide little to no benefit in subjects with type 2 diabetes. Moreover, neuropathy has been shown to develop in humans as well as animal models in stages of prediabetes/insulin resistance and in the absence of overt hyperglycemia. Given the increasing incidence of both type 1 and type 2 diabetes and obesity in the worldwide population and the impact diabetic neuropathy has on the quality of life of patients and their families, a strategy for the early diagnosis and discovery of an effective treatment is needed.

Clinical studies over the last few years have introduced determination of sensitivity and morphometry of sensory nerves in the skin and cornea as a means for early detection of diabetic neuropathy. However, applicability of these newer diagnostic tools in the clinic has not been demonstrated. Application of the more recognized approaches for diagnosing and staging diabetic neuropathy such as patient questionnaires, determining thermal and mechanical sensitivities, and examination of nerve conduction velocities also require standardization. Approximately, 30% of diabetics with neuropathy have associated pain, and management of this pain has been a challenge for clinicians. Choice of the correct drug(s), dosage, and patient management seems to be based on individual needs. Overall, diagnosis and management of diabetic neuropathy in the patient have not progressed significantly for many years and this needs to change.

Animal studies have provided an array of insight to the etiology of diabetic neuropathy. However, translation of these findings to an effective treatment for the patient has been unsuccessful. There are many factors that may account for these poor outcomes and these shortfalls need to be addressed. Therefore, continued preclinical studies are needed, perhaps using more predictive/translational endpoints and combination therapies, in order to identify an effective treatment that at minimum will slow progression or even repair nerve damage caused by prediabetes/diabetes.

For this special issue we seek clinical and preclinical studies on the diagnosis and treatment of diabetic neuropathy. We will also consider research articles as well as review articles that address the challenges and potential solutions in the diagnosis and treatment of diabetic neuropathy.

Potential topics include but are not limited to the following:

  • New tools for the early diagnosis of diabetic neuropathy
  • Neuropathy in prediabetes: is this the time for treatment?
  • Standardization of the diagnosis of diabetic neuropathy in the clinic
  • Is diabetic neuropathy different in type 1 versus type 2 diabetes?
  • Risk factors for development of diabetic neuropathy in type 2 diabetes
  • Management of diabetic neuropathy in the patient: pain and prognosis
  • Challenges of translation of preclinical studies to the bed side
  • Animal models, new and old, for the study of diabetic neuropathy
  • New etiologies/mechanisms of diabetic neuropathy
  • Potential new treatments, clinical or preclinical, for diabetic neuropathy
  • Diabetic neuropathy and foot ulcers
  • Exercise and diabetic neuropathy: can life style changes improve outcome?
  • Diabetic neuropathy in youth
  • Diabetic neuropathy and the risk of falling in the elderly
  • Can a drug to treat diabetic neuropathy ever gain approval in the current regulatory landscape?

Articles

  • Special Issue
  • - Volume 2018
  • - Article ID 5378439
  • - Editorial

Diabetic Neuropathy: New Insights to Early Diagnosis and Treatments

Mark Yorek | Rayaz A. Malik | ... | Soroku Yagihashi
  • Special Issue
  • - Volume 2018
  • - Article ID 2309108
  • - Research Article

Preserved Expression of Skin Neurotrophic Factors in Advanced Diabetic Neuropathy Does Not Lead to Neural Regeneration despite Pancreas and Kidney Transplantation

František Saudek | Monika Cahová | ... | Claudia Sommer
  • Special Issue
  • - Volume 2018
  • - Article ID 8065938
  • - Research Article

The Influence of Clinically Diagnosed Neuropathy on Respiratory Muscle Strength in Type 2 Diabetes Mellitus

Birgit L. M. Van Eetvelde | Dirk Cambier | ... | Patrick Calders
  • Special Issue
  • - Volume 2018
  • - Article ID 9763507
  • - Research Article

Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes Mellitus

Fabiana Picconi | Giorgia Mataluni | ... | Simona Frontoni
  • Special Issue
  • - Volume 2018
  • - Article ID 3827301
  • - Review Article

Diabetic Enteropathy: From Molecule to Mechanism-Based Treatment

Theresa Meldgaard | Søren Schou Olesen | ... | Christina Brock
  • Special Issue
  • - Volume 2018
  • - Article ID 5647981
  • - Research Article

Markers of Local Inflammation and Bone Resorption in the Acute Diabetic Charcot Foot

Rasmus Bo Jansen | Tomas Møller Christensen | ... | Ole Lander Svendsen
  • Special Issue
  • - Volume 2018
  • - Article ID 4735659
  • - Research Article

Changes in Immunoreactivity of Sensory Substances within the Enteric Nervous System of the Porcine Stomach during Experimentally Induced Diabetes

Michał Bulc | Katarzyna Palus | ... | Łukasz Zielonka
  • Special Issue
  • - Volume 2018
  • - Article ID 2967127
  • - Research Article

Effect of Dietary Content of Menhaden Oil with or without Salsalate on Neuropathic Endpoints in High-Fat-Fed/Low-Dose Streptozotocin-Treated Sprague Dawley Rats

Eric P. Davidson | Lawrence J. Coppey | ... | Mark A. Yorek
  • Special Issue
  • - Volume 2018
  • - Article ID 8516276
  • - Clinical Study

In Vivo Corneal Confocal Microscopy Detects Improvement of Corneal Nerve Parameters following Glycemic Control in Patients with Type 2 Diabetes

Xiaofan Jia | Xiaogang Wang | ... | Lixin Guo
Journal of Diabetes Research
 Journal metrics
Acceptance rate31%
Submission to final decision71 days
Acceptance to publication25 days
CiteScore3.020
Impact Factor3.040
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.